2min chapter

The Peter Attia Drive cover image

#175 - Matt Kaeberlein, Ph.D.: The biology of aging, rapamycin, and other interventions that target the aging process

The Peter Attia Drive

CHAPTER

Is There a Commercial Problem to Do?

This strikes me as a project that's almost too big for academics because it's too disjointed. But at the same time, it's not particularly interesting commercial problem to solve. So who should do it? Who might doing it? I mean, i think this would fall maybe in the realm of what calico could do. They've got the resources. And they've got the expertise. You can't kill the animals, right? So you could or be sort of restricted to blood. There are some practical aspects, but there's no, there's no technical barrier to doing that. It depends on whether you're talking about doing this pre clinically or clinically, right? I actually

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode